A carregar...
A Bayesian Adaptive Design for Cancer Phase I Trials Using a Flexible Range of Doses
We present a Bayesian adaptive design for dose finding in cancer phase I clinical trials. The goal is to estimate the maximum tolerated dose (MTD) after possible modification of the dose range during the trial. Parametric models are used to describe the relationship between the dose and the probabil...
Na minha lista:
| Publicado no: | J Biopharm Stat |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5832533/ https://ncbi.nlm.nih.gov/pubmed/28858566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10543406.2017.1372774 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|